The Inflation Reduction Act (IRA) made significant changes to the Medicare drug programs.[1] Although the IRA may have been intended to make medicines more affordable for beneficiaries and the federal ...

Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...

In 2026, there will be fewer Medicare Advantage prescription drug plans available — 32 — down from 34 in 2025, according to reporting by KFF. That’s a drop from the peak of 36 plans in 2024 but still ...

As of 2022, there were 15 oral and injectable MS drugs across seven types of "classes," or groups of medication that work in similar ways. These treatments are all pricey, usually costing $5,000 to ...

MIAMI--(BUSINESS WIRE)--HealthSun Health Plans today announced that the Centers for Medicare & Medicaid Services (CMS) awarded its Medicare Advantage plans a 5-Star rating for the fifth year in a row, ...

Fall enrollment is on. Some plans are raising premiums for Part D, which covers prescriptions, by $50 or more per month, while others are lowering them.

Medicare patients may have noticed a cost increase in prescription drugs due as drug insurers respond to a cap placed on out-of-pocket costs. “It’s a complicated story,” said Rich Daly, a senior ...

ORANGE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the ...